SE522246C2 - Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion - Google Patents

Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Info

Publication number
SE522246C2
SE522246C2 SE9700708A SE9700708A SE522246C2 SE 522246 C2 SE522246 C2 SE 522246C2 SE 9700708 A SE9700708 A SE 9700708A SE 9700708 A SE9700708 A SE 9700708A SE 522246 C2 SE522246 C2 SE 522246C2
Authority
SE
Sweden
Prior art keywords
use according
astaxanthin
preparation
oral preparation
helicobacter
Prior art date
Application number
SE9700708A
Other languages
English (en)
Swedish (sv)
Other versions
SE9700708D0 (sv
SE9700708L (sv
Inventor
Torkel Wadstroem
Paer Alejung
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Priority to SE9700708A priority Critical patent/SE522246C2/sv
Publication of SE9700708D0 publication Critical patent/SE9700708D0/xx
Priority to CA002280715A priority patent/CA2280715C/en
Priority to DE69815677T priority patent/DE69815677D1/de
Priority to NZ337080A priority patent/NZ337080A/en
Priority to AT98906921T priority patent/ATE243030T1/de
Priority to AU62951/98A priority patent/AU719090B2/en
Priority to US09/367,838 priority patent/US6262316B1/en
Priority to PL98335370A priority patent/PL335370A1/xx
Priority to KR1019997007239A priority patent/KR100569908B1/ko
Priority to IL13112998A priority patent/IL131129A/en
Priority to JP53722298A priority patent/JP4267076B2/ja
Priority to CN98802850A priority patent/CN1119994C/zh
Priority to PCT/EP1998/000628 priority patent/WO1998037874A1/en
Priority to EP98906921A priority patent/EP0981338B1/en
Publication of SE9700708L publication Critical patent/SE9700708L/
Priority to NO19994109A priority patent/NO327303B1/no
Publication of SE522246C2 publication Critical patent/SE522246C2/sv
Priority to JP2006032853A priority patent/JP4463773B2/ja
Priority to JP2009295816A priority patent/JP2010111689A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)
SE9700708A 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion SE522246C2 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE9700708A SE522246C2 (sv) 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
EP98906921A EP0981338B1 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
KR1019997007239A KR100569908B1 (ko) 1997-02-27 1998-02-05 헬리코박터 에스피 감염의 예방 및 치료에 사용되는 경구용제제
JP53722298A JP4267076B2 (ja) 1997-02-27 1998-02-05 Ｈｅｌｉｃｏｂａｃｔｅｒ種による感染症の予防および治療用経口製剤
NZ337080A NZ337080A (en) 1997-02-27 1998-02-05 Oral preparation containing xanthophylles such as astaxanthin to helicobacter sp.infection
AT98906921T ATE243030T1 (de) 1997-02-27 1998-02-05 Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
AU62951/98A AU719090B2 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
US09/367,838 US6262316B1 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp. infection
PL98335370A PL335370A1 (en) 1997-02-27 1998-02-05 Orally administered preparation for preventing and treating bacterial infections caused by helicobacter sp.
CA002280715A CA2280715C (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp.infection
IL13112998A IL131129A (en) 1997-02-27 1998-02-05 An oral preparation for the prevention and treatment of infection caused by the Helicobacter strain
DE69815677T DE69815677D1 (de) 1997-02-27 1998-02-05 Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
CN98802850A CN1119994C (zh) 1997-02-27 1998-02-05 用于预防和治疗螺杆菌属感染的口服制剂
PCT/EP1998/000628 WO1998037874A1 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
NO19994109A NO327303B1 (no) 1997-02-27 1999-08-25 Anvendelse av astaxanthin for fremstilling av et preparat for profylaktisk og terapeutisk behandling av Helicobacter sp.-infeksjon
JP2006032853A JP4463773B2 (ja) 1997-02-27 2006-02-09 Ｈｅｌｉｃｏｂａｃｔｅｒ種による感染症の予防および治療用経口製剤
JP2009295816A JP2010111689A (ja) 1997-02-27 2009-12-25 Ｈｅｌｉｃｏｂａｃｔｅｒ種による感染症の予防および治療用経口製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700708A SE522246C2 (sv) 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Publications (3)

Publication Number Publication Date
SE9700708D0 SE9700708D0 (sv) 1997-02-27
SE9700708L SE9700708L (sv) 1998-08-28
SE522246C2 true SE522246C2 (sv) 2004-01-27

Family

ID=20405957

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700708A SE522246C2 (sv) 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Country Status (15)

Country Link
US (1) US6262316B1 (no)
EP (1) EP0981338B1 (no)
JP (3) JP4267076B2 (no)
KR (1) KR100569908B1 (no)
CN (1) CN1119994C (no)
AT (1) ATE243030T1 (no)
AU (1) AU719090B2 (no)
CA (1) CA2280715C (no)
DE (1) DE69815677D1 (no)
IL (1) IL131129A (no)
NO (1) NO327303B1 (no)
NZ (1) NZ337080A (no)
PL (1) PL335370A1 (no)
SE (1) SE522246C2 (no)
WO (1) WO1998037874A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE524337C2 (sv) * 1998-10-16 2004-07-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7078040B2 (en) 2000-03-27 2006-07-18 Fuji Chemical Industry Co., Ltd. Method of inhibiting the expression of inflammatory cytokines and chemokines
SE0001071D0 (sv) * 2000-03-27 2000-03-27 Astacarotene Ab Method of inhibiting the expression of inflammatory cytokines and chemokines
KR100481880B1 (ko) * 2001-12-05 2005-04-11 (주)바이오벤 목이버섯으로부터 헬리코박터 파이로리의 부착억제성분을추출하는 방법 및 그 헬리코박터 파이로리의 부착억제성분
CA2473698A1 (en) * 2002-01-16 2003-07-31 Natural Alternatives International, Inc. Anti-inflammatory formulations
AU2002329108A1 (en) * 2002-09-03 2004-03-29 Centro De Investigacion En Alimentacion Y Desarrollo A.C. Method of preparing chitosan microcapsules of astaxanthin and product thus obtained
US20040151761A1 (en) * 2003-02-05 2004-08-05 The Procter & Gamble Company Methods and compositions utilizing astaxanthin
GB0314624D0 (en) 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
CN1882354B (zh) 2003-09-12 2012-07-04 捷通国际有限公司 细胞因子调节剂及相关用法
JP4933097B2 (ja) 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法
EP1750723A1 (en) 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CN1324989C (zh) * 2005-10-10 2007-07-11 华南理工大学 含虾青素营养食品及其制备方法
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
JP5497372B2 (ja) * 2009-08-19 2014-05-21 バイオジェニック株式会社 非ステロイド性抗炎症薬起因性潰瘍の予防・治療薬
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
CN107691751A (zh) * 2017-11-12 2018-02-16 张雅萍 一种美容、香体的虾青素夹心凝胶糖果及其制备方法
US11065269B1 (en) * 2018-11-15 2021-07-20 Samuel L. Shepherd Method of using astaxanthin for the treatment of diseases, and more particularly, the treatment of cancer
CN114732130B (zh) * 2022-04-07 2024-01-23 云南雨藻生物科技有限公司 含雨生红球藻且抑制胃粘膜受损的组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH0799924A (ja) 1993-09-30 1995-04-18 Nippon Suisan Kaisha Ltd アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法
JPH07300421A (ja) * 1994-04-28 1995-11-14 Itano Reitou Kk 抗炎症剤
US5886053A (en) 1995-02-03 1999-03-23 Basf Aktiengesellschaft Use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物

Also Published As

Publication number Publication date
CA2280715C (en) 2008-10-07
KR20000070973A (ko) 2000-11-25
JP4267076B2 (ja) 2009-05-27
AU6295198A (en) 1998-09-18
ATE243030T1 (de) 2003-07-15
CA2280715A1 (en) 1998-09-03
JP2001517213A (ja) 2001-10-02
NO994109L (no) 1999-10-27
AU719090B2 (en) 2000-05-04
CN1248912A (zh) 2000-03-29
NO994109D0 (no) 1999-08-25
JP2010111689A (ja) 2010-05-20
CN1119994C (zh) 2003-09-03
IL131129A (en) 2004-06-20
EP0981338A1 (en) 2000-03-01
KR100569908B1 (ko) 2006-04-10
WO1998037874A1 (en) 1998-09-03
IL131129A0 (en) 2001-01-28
SE9700708D0 (sv) 1997-02-27
PL335370A1 (en) 2000-04-25
DE69815677D1 (de) 2003-07-24
JP2006188526A (ja) 2006-07-20
US6262316B1 (en) 2001-07-17
JP4463773B2 (ja) 2010-05-19
NZ337080A (en) 2001-03-30
NO327303B1 (no) 2009-06-02
SE9700708L (sv) 1998-08-28
EP0981338B1 (en) 2003-06-18

Similar Documents

Publication Publication Date Title
SE522246C2 (sv) Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
Zhou et al. Effect of the flavonoid baicalein as a feed additive on the growth performance, immunity, and antioxidant capacity of broiler chickens
Najafi et al. Performance, blood metabolites and immunocompetaence of broiler
KR101228993B1 (ko) 발효 및 배양 방법, 식물발효 엑기스, 식물발효 엑기스분말 및 이 식물발효 엑기스 배합물
Li et al. Protective effects of γ-irradiated Astragalus polysaccharides on intestinal development and mucosal immune function of immunosuppressed broilers
Sjunnesson et al. High Intake of Selenium,-Carotene, and Vitamins A, C, and E Reduces Growth of Helicobacter pylori in the Guinea Pig
Kang et al. Efficacy of polymers from spontaneous carotenoid oxidation in reducing necrotic enteritis in broilers
Yu et al. Trans-anethole ameliorates intestinal injury through activation of Nrf2 signaling pathway in subclinical necrotic enteritis-induced broilers
Khaligh et al. Effect of probiotic administration route and dietary nutrient density on growth performance, gut health, and some hematological variables in healthy or Eimeria infected broiler chickens
Edens et al. Atypical Escherichia coli strains and their association with poult enteritis and mortality syndrome
Mao et al. The effect of dietary Yucca schidigera extract supplementation on productive performance, egg quality, and gut health in laying hens with Clostridium perfringens and coccidia challenge
Ivanova et al. A plant polyphenol-rich extract restores the suppressed functions of phagocytes in influenza virus-infected mice
CN109939138B (zh) 一种抗鸡球虫的中草药微生态制剂及其应用
US20220015406A1 (en) Compositions and Methods for Improving Quality of Life in Patients with Autism Spectrum Disorder
CN117017970A (zh) 一种缓解氧化应激的药物组合和应用
Shojadoost et al. Effects of virginiamycin against experimentally induced necrotic enteritis in broiler chickens vaccinated or not with an attenuated coccidial vaccine
WO2019117616A1 (ko) 아가토바쿨룸 속 균주를 유효성분으로 함유하는 자폐 범주성 장애의 예방, 개선 또는 치료용 조성물
CA2346647C (en) Treatment of dyspepsia
Koščová et al. Effect of two plant extracts and Lactobacillus fermentum on colonization of gastrointestinal tract by Salmonella enterica var. Düsseldorf in chicks
Siben et al. Studying efficiency of the method of treating nematodoses in sheep
Ma et al. Influence of Ligustrum lucidum and Schisandra chinensis fruits on antioxidative metabolism and immunological parameters of layer chicks
ITRM20100274A1 (it) Composizioni per il trattamento della infezione da helicobacter pylori.
US20220160758A1 (en) Antiviral, antibacterial and/or anti fungal compositions, applications and therapy
Liu Effects of plant extracts on immune function and disease resistance in pigs
Basir et al. In Vitro Anti-Vibrio Activity of Miana Leaves (Coleus scutellarioides (L) Benth)

Legal Events

Date Code Title Description
NUG Patent has lapsed